Harper Government Supports Pharmaceutical Manufacturing in Greater Toronto Area

TORONTO, ONTARIO--(Marketwired - Jan. 16, 2015) - Dalton Pharma Services will expand its manufacturing capacity thanks to an investment of up to $2.085 million announced today by FedDev Ontario Minister Gary Goodyear and Member of Parliament for York Centre Mark Adler.

The Harper Government's repayable contribution is through FedDev Ontario's Investing in Business Growth and Productivity initiative, which is aimed at helping established businesses to expand their operations, invest in productivity improvements and compete globally.

Dalton Pharma Services, a contract manufacturing and drug development research company, will use the federal funding to buy equipment and renovate the company's existing facility. This will enable Dalton Pharma Services to manufacture more specialized drug products. The project is expected to create 21 new full-time skilled positions in the life sciences sector during the project and an additional 13 following project completion.

Quick Facts

• Located in North York, Dalton Pharma Services has been in operation for 28 years and has a solid track record of success. The company is a spin-off from York University and offers manufacturing, chemistry, and analytical services on a contract basis to the global biotechnology and pharmaceutical industries.
• The project will position the company to significantly expand its capacity to manufacture powder drugs, improve internal drug development capabilities, and broaden their service offerings to clients.
• FedDev Ontario's contribution is matched by an additional $6.3 million from Dalton Pharma Services.
• Investing in Business Growth and Productivity funding is available for eligible small- and medium-sized enterprises and not-for-profit industry associations or regional economic development organizations.

Quotes

"Today's announcement means creating jobs and growth, and strengthening the life sciences cluster here in the Greater Toronto Area. Thanks to our Government's support, this funding will help Dalton Pharma Services to expand its services to global biotechnology and pharmaceutical companies."

- The Honourable Gary Goodyear, Minister for the Federal Economic Development Agency for Southern Ontario (FedDev Ontario)

"This investment is great news for the Greater Toronto Area as it will position Dalton Pharma Services as a leader in the expanding niche pharmaceutical manufacturing market and enable it to offer more specialized services and create local jobs in the life sciences field."

- Mark Adler, Member of Parliament for York Centre

"Dalton is very pleased and grateful to have been selected by FedDev Ontario for this important funding. The resulting strategic investments we are making in sterile manufacturing will help Dalton advance its leadership position in aseptic processing technologies, and accelerate the application of these innovations to our customer's leading-edge pharmaceutical products."

- Peter Pekos, President and CEO, Dalton Chemical Laboratories Inc.

Related Products

Investing in Business Growth and Productivity funding announcement for Dalton (speech)

Associated Links

Investing in Business Growth and Productivity initiative

Dalton Pharma Services

Subscribe to our news updates and follow us on Twitter @FedDevOntario